Minerva Neurosciences, Inc. (NERV)
NASDAQ: NERV · Real-Time Price · USD
4.540
+0.120 (2.71%)
At close: Aug 18, 2026, 4:00 PM EDT
4.600
+0.060 (1.32%)
After-hours: Aug 18, 2026, 4:37 PM EDT
Minerva Neurosciences Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
7
Market Cap
216.77M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Compugen | 74.00M |
| Cellectis | 63.82M |
| Invivyd | 58.37M |
| Atrium Therapeutics | 35.84M |
| Tonix Pharmaceuticals Holding | 29.10M |
| Alector | 13.86M |
| YD Bio | 510.36K |
NERV News
- 2 days ago - Minerva upgraded to Buy from Hold at Jefferies - TheFly
- 11 days ago - Minerva Neurosciences Provides Second Quarter 2026 Financial Results and Business Updates - GlobeNewsWire
- 11 days ago - Minerva Neurosciences Earnings release: Q2 2026 - Filings
- 11 days ago - Minerva Neurosciences Quarterly report: Q2 2026 - Filings
- 2 months ago - Minerva Neurosciences Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 2 months ago - Minerva Neurosciences Transcript: AGM 2026 - Transcripts
- 2 months ago - Minerva Neurosciences Establishes Scientific Advisory Board to Advance Development of Roluperidone and Future Pipeline Programs - GlobeNewsWire
- 3 months ago - Minerva Neurosciences Slides: Corporate presentation - Filings